Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Serstech ABOSTO:SERT 33 Debt-to-Equity is 0.28 as of Jun. 2026, which is 367% above its 10-year median of 0.06. GuruFocus rates OSTO:SERT with a GF Score™ of 33/100 and a GF Value™ of kr0.40 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 1,421 Chemicals companies, Serstech AB ranks better than 57.07% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Serstech AB's Debt-to-Equity or its related term are showing as below:
OSTO:SERT'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.03 Med: 0.06 Max: 0.28
Current: 0.28
During the past 13 years, the highest Debt-to-Equity Ratio of Serstech AB was 0.28. The lowest was 0.03. And the median was 0.06.
OSTO:SERT's Debt-to-Equity is ranked better than 57.07% of 1421
companies
in the Chemicals industry
Industry Median: 0.36
vs OSTO:SERT: 0.28
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Serstech AB Debt-to-Equity Related Terms
Serstech AB Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Serstech AB's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Serstech AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Serstech AB Debt-to-Equity vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Serstech AB's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Serstech AB's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Serstech AB (OSTO:SERT) has a Debt-to-Equity of 0.28 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Serstech AB and its competitors. This is 367% above median its historical median of 0.06. Over the past decade, Serstech AB's Debt-to-Equity has ranged from 0.03 to 0.28. According to the industry distribution chart, Serstech AB ranks #610 out of 1421 companies in the Chemicals industry, placing it in the top 42.9%.
Is Serstech AB's Debt-to-Equity too high?
Serstech AB's current Debt-to-Equity of 0.28 is 367% above median its 10-year median of 0.06. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 0.28. The Chemicals industry median Debt-to-Equity is 0.36. Serstech AB's value of 0.28 is 22.2% below this industry median. Based on the distribution chart, Serstech AB ranks #610 out of 1421 companies in the Chemicals industry, which is above the industry midpoint. Overall, Serstech AB has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Serstech AB's Debt-to-Equity compare to DOW?
According to the Chemicals industry distribution chart, Serstech AB ranks #610 out of 1421 companies for Debt-to-Equity. This puts Serstech AB in the upper half of its industry. The industry median Debt-to-Equity is 0.36. Serstech AB's value of 0.28 is 22.2% below this benchmark. Historically, Serstech AB's own Debt-to-Equity has ranged from 0.03 to 0.28 over the past decade. While the company's 10-year median is 0.06 vs. the industry median of 0.36, Serstech AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Chemicals company?
The median Debt-to-Equity among Chemicals companies is 0.36, based on 1,421 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Serstech AB's current Debt-to-Equity of 0.28 is 22.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Serstech AB and its competitors. For the Chemicals industry, the median Debt-to-Equity is 0.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Serstech AB's current Debt-to-Equity is 0.28, which is 367% above median its own 10-year median of 0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Serstech AB stock overvalued right now?
Based on GuruFocus' analysis, Serstech AB (OSTO:SERT) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.40, compared to a current price of kr0.54 — trading 34.5% above its estimated fair value. The current Debt-to-Equity is 0.28, which is 367% above median its 10-year median of 0.06 and 22.2% below the Chemicals industry median of 0.36. Serstech AB's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Serstech AB (OSTO:SERT), the current Debt-to-Equity is 0.28 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Serstech AB (OSTO:SERT) Overvalued in 2026?
Based on GuruFocus' analysis, Serstech AB stock appears to be overvalued.
The current stock price of kr0.54 is trading 34.5% above its estimated GF Value™ of kr0.40.
GuruFocus considers Serstech AB to be Significantly Overvalued.
Key valuation signals for OSTO:SERT:
Debt-to-Equity: 0.28 (367% above median its 10-year median of 0.06)
GF Value™: kr0.40 vs. price of kr0.54 (34.5% above fair value)
Industry Position: 22.2% below the Chemicals median (#610 of 1421)
No single metric tells the full story. See the OSTO:SERT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Serstech AB is engaged in chemical related products which help in the measurement and identification of chemicals. It offers Handheld Raman Spectrometer; Chemdash, Management and Reporting Software and Validated Data-Enriched and Complete Libraries. The company's solutions are used in the pharmaceutical production industry.
33GF Score
Get the complete analysis for OSTO:SERT
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SERT has been successfully added to your 
